Back to search
FDAFDA · Food and drugs·Recall number D-669-2013

Test Cyp 250 mg-lidocaine 5 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907

Published July 10, 2013 · Recall initiated: March 20, 2013

Summary

FDA records drug Class II recall D-669-2013, published July 10, 2013 and initiated March 20, 2013. Recalling firm: Clinical Specialties Compounding Pharmacy; Status: Terminated; Reported quantity: 10ml total; Lot: Lot number CABCCABB:74, Exp date: 5/19/2013 and Lot number CABCCABB:31 Exp date: 7/29/2013. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Clinical Specialties Compounding Pharmacy
Distributor
FL, GA and SC.
Lot
Lot number CABCCABB:74, Exp date: 5/19/2013 and Lot number CABCCABB:31 Exp date: 7/29/2013.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Test Cyp 250 mg-lidocaine 5 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907 recalled?

Yes. FDA published recall D-669-2013 on July 10, 2013. Reported hazard: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

What should I do if I have this product?

Voluntary: Firm initiated · Telephone